Inflammation of the liver due to NAFLD causes increased levels of proinflammatory and procoagulant factors and decreases levels of adipokines and adiponectin (protective factors), thus contributing to the pathogenesis of CRC in patients with NAFLD [143]. Here, ADIPOQ is linked to metabolic dysfunction-associated steatotic liver disease.